Calvert Investment Management’s Zimmer Biomet ZBH Stock Holding History

Calvert Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,785	Closed	-$888K	–	686
2015 Q1	$888K	Buy	7,785 +1,007	+15%	+$115K	0.06%	243
2014 Q4	$746K	Buy	6,778 +395	+6%	+$41.6K	0.05%	261
2014 Q3	$623K	Buy	+6,383	New	+$628K	0.05%	271

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Calvert Investment Management's ZBH Position: Q2 2015 in Review

Calvert Investment Management sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 7,785 shares — an estimated $888K sold.

Calvert Investment Management first reported a position in ZBH in Q3 2014 and held it in 3 quarters. The position peaked at $888K in Q1 2015. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

Calvert Investment Management reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
Calvert Investment Management sold 7,785 Zimmer Biomet shares in Q2 2015, an estimated $888K.
Calvert Investment Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 3 quarters.
Calvert Investment Management's Zimmer Biomet position peaked at $888K in Q1 2015.
749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Calvert Investment Management's 13F filing for Q2 2015, filed 4 Aug 2015.